Construction work on the $64m mRNA Vaccine and Biomanufacturing Center Expansion located in Charlottetown, Prince Edward Island, Canada commenced in Q2 2022. It was announced in Q1 2019.
The project involves the expansion of a 3,344m2 biopharmaceutical center in Charlottetown, Prince Edward Island, Canada.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The project includes the following:
1. Construction of an administrative building
2. Construction of a cafeteria
3. Construction of a logistics center
4. Construction of a central power plant
5. Construction of research centers
6. Construction of testing centers
7. Construction of storage facilities
8. Construction of laboratories
9. Construction of parking facilities
10. Installation of machinery
11. Installation of safety and security systems
Construction on the project is expected to be completed by Q4 2023.
Owners of the project include Canada-based BioVectra.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCanada-based BioVectra is the architect and engineering design consultant for the mRNA Vaccine and Biomanufacturing Center Expansion, while Charlottetown City Council is the planning authority.
